NET PROFIT (x1000 SEK)
EMPLOYEES
Solural Pharma ApS
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
2,047
|
9,064
|
4,078 |
Total assets |
14,705
|
19,492
|
12,596 |
Current assets |
13,096
|
17,890
|
11,313 |
Current liabilities |
4,231
|
4,579
|
2,862 |
Equity capital |
10,474
|
14,911
|
9,734 |
- share capital |
119
|
120
|
110 |
Employees (average) |
7
![]() |
7
![]() |
7 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
71.2%
|
76.5%
|
77.3% |
Turnover per employee |
0
![]() |
0
![]() |
0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) | |||
Current ratio |
309.5%
|
390.7%
|
395.3% |
Return on equity (ROE) |
19.5%
|
60.8%
|
41.9% |
Change turnover |
0
![]() |
0
![]() |
0 |
Change turnover % | |||
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.